Francis Hinds Clinical Oncology Society of Australia Annual Scientific Meeting 2024

Abstracts this author is presenting:

• Collaborative, patient guided approach to a first-in-human study for advanced cancer — Afternoon Tea, Exhibition & Poster Session 1
• TRIAL IN PROGRESS: An open label phase I multicenter clinical trial of S095035 (MAT2A inhibitor) in adult participants with advanced or metastatic solid tumors with homozygous deletion of MTAP — Afternoon Tea, Exhibition & Poster Session 1